From a plasma donation perspective, the active ingredient (the peptide itself) is what the medical staff will be interested in
While current treatments can help manage many PD symptoms, they do not address what causes the disease and therefore cannot prevent its progression
This happens for a variety of reasons, but one common one is that as you lose weight, your body needs fewer calories
A 2021 review in Obesity Reviews found that patients taking weight-promoting medications alongside GLP-1s had significantly reduced weight loss compared to those not taking these drugs
In clinical trials encompassing over 10,000 participants with exposure periods up to 72 weeks, cancer incidence rates were low and comparable between tirzepatide and comparator groups
Many people starting GLP-1 receptor agonist medications for type 2 diabetes or weight management naturally wonder when they'll notice improvements